Detalhe da pesquisa
1.
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
Blood
; 143(6): 496-506, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879047
2.
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
Blood
; 139(9): 1330-1339, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570879
3.
Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain.
Am J Hematol
; 99(5): 922-937, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38414188
4.
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(1): 91-103, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895487
5.
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
Cancer
; 127(22): 4233-4239, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374445
6.
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Cancer
; 126(23): 5077-5087, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965680
7.
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1859-1868, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132455
8.
The acceleration of CAR-T therapy in non-Hodgkin lymphoma.
Hematol Oncol
; 37(3): 233-239, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427551
9.
6-thioguanine: a drug with unrealized potential for cancer therapy.
Oncologist
; 19(7): 760-5, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24928612
10.
ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615990
11.
Post-transplantation cyclophosphamide is associated with increased bacterial infections.
Bone Marrow Transplant
; 59(1): 76-84, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903992
12.
Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.
Blood Adv
; 7(1): 32-39, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260735
13.
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
Blood Adv
; 7(12): 2746-2757, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827681
14.
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Blood Adv
; 7(22): 7007-7016, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792849
15.
Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.
Transplant Cell Ther
; 28(6): 306.e1-306.e7, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248777
16.
Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma.
Transplant Cell Ther
; 28(8): 487.e1-487.e7, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609865
17.
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Transplant Cell Ther
; 28(4): 187.e1-187.e10, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081472
18.
Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease.
Transplant Cell Ther
; 27(11): 937.e1-937.e7, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380090
19.
Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation.
Transplant Cell Ther
; 27(5): 391-403, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33965177
20.
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.
Transplant Cell Ther
; 27(12): 993.e1-993.e8, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34507002